131 related articles for article (PubMed ID: 2663216)
1. Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapy.
Mathé G; Reizenstein P; Eriguchi M
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):75-92. PubMed ID: 2663216
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials of the treatment of minimal residual tumours.
Mathé G; Reizenstein P; Eriguchi M
Drugs Exp Clin Res; 1986; 12(1-3):83-98. PubMed ID: 3525078
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapy.
Mathé G; Reizenstein P; Eriguchi M
Suppl J Med Oncol Tumor Pharmacother; 1988; 1():75-92. PubMed ID: 3074229
[No Abstract] [Full Text] [Related]
4. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy and the kinetic refractoriness of minimal residual tumors.
Reizenstein P; Mathé G
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):57-8. PubMed ID: 2743532
[TBL] [Abstract][Full Text] [Related]
6. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
7. [Why complete or partial response can not be achieved by immunotherapy].
Fujimoto S; Nitta K
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):459-63. PubMed ID: 1690966
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
10. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
Kimura H; Yamaguchi Y
Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
[TBL] [Abstract][Full Text] [Related]
11. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
12. New survival curve model for comparison of adjuvant therapy of malignant diseases.
Eriguchi M; Mathé G
Biomed Pharmacother; 1986; 40(4):143-7. PubMed ID: 3790708
[TBL] [Abstract][Full Text] [Related]
13. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
14. Curative cancer chemotherapy.
Frei E
Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
[TBL] [Abstract][Full Text] [Related]
15. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
16. Passive, adoptive, and active immunotherapy: a review of clinical trials in cancer.
Mathé G
Cancer Detect Prev Suppl; 1987; 1():279-90. PubMed ID: 3319146
[TBL] [Abstract][Full Text] [Related]
17. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy in radical surgery of colorectal carcinoma].
Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A
Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635
[TBL] [Abstract][Full Text] [Related]
19. Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help.
Garay RP; Viens P; Bauer J; Normier G; Bardou M; Jeannin JF; Chiavaroli C
Eur J Pharmacol; 2007 Jun; 563(1-3):1-17. PubMed ID: 17383632
[TBL] [Abstract][Full Text] [Related]
20. [Role of chemotherapy in adjuvant treatment of breast cancer: modulation of the immune status].
Fargeot P; Guerrin J
Bull Cancer; 1984; 71(4):346-53. PubMed ID: 6388673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
